Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Vanguard Total International Stock Index Fund ETF (VXUS) Price & Performance

Hinge Health Inc. Class A Common StockTrade
Vanguard Total International Stock Index Fund ETFTrade

Price performance (Past 24H)

Key statistics

Hinge Health Inc. Class A Common Stock vs Vanguard Total International Stock Index Fund ETF — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Vanguard Total International Stock Index Fund ETF trades at $83.12 (market cap $665.70B). The key difference: Vanguard Total International Stock Index Fund ETF is far larger — about 78.5× Hinge Health Inc. Class A Common Stock's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Vanguard Total International Stock Index Fund ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Vanguard Total International Stock Index Fund ETF for 56 Days on average.

HNGEVXUS
Market Cap
$8.48B$665.70B
Volume
879,7994,659,186
Sector
HealthSector/Thematic
52-Week High
$105.14$88.41
52-Week Low
$31.17$72.19
Typical Hold Time
0 Days56 Days
Enterprise Value
$8.10B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Hinge Health Inc. Class A Common Stock

Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.

The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.

Vanguard Total International Stock Index Fund ETF

VXUS trades at $84.54 with minimal daily movement (+0.12%). Technical indicators show bearish momentum with moving averages signaling sell pressure, while oscillators remain neutral. The ETF provides broad international stock exposure outside the U.S., offering diversification benefits. Recent institutional activity shows growing interest, with firms like QRG Capital increasing positions by 97.8% in Q2 2026 (SEC filing, September 2026).

VXUS offers cost-effective international diversification but faces currency and geopolitical risks. Current bearish technicals suggest near-term pressure, while long-term prospects depend on global market performance versus U.S. equities. The upcoming $0.16 dividend in September 2026 provides income, but foreign tax credit limitations in IRAs may reduce net returns for some investors (24/7 Wall Street, August 2026).

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HNGE
100% Buy0% Sell
Avg holding period · 0 Days
VXUS
99% Buy1% Sell
Avg holding period · 56 Days

Top news

Latest headlines on both assets

About Hinge Health Inc. Class A Common Stock

Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.

Read more on HNGE →

About Vanguard Total International Stock Index Fund ETF

VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.

Read more on VXUS →